OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
July 02, 2011
Getting an answer is easy-asking the right question is apparently more difficult.
Member states in the EU are working to implement the newly passed Falsified Medicines Directive.
Follow-on versions of complex biologics require extensive expertise in development and regulatory procedures.
Better strategies and practices in sourcing and procurement can contribute to the bottom line.
June 02, 2011
A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Industry struggles to curb drug abuse, diversion, and disruptions in supply.
Sometimes, there are just too many cooks in the kitchen.
FDA added a searchable database of inspection data to its website. The database lists the names and addresses of facilities that the agency inspected during fiscal years 2009 and 2010.
India's drug pricing authority increased the retail costs of certain domestically manufactured drugs, but not those of imported drug products. Pharma is asking why.
May 26, 2011
Global spending on medicines will total almost $1.1 trillion by 2015, according to an IMS Institute for Healthcare Informatics study.